These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 23559371)
21. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Jiang Q; Zheng N; Bu L; Zhang X; Zhang X; Wu Y; Su Y; Wang L; Zhang X; Ren S; Dai X; Wu D; Xie W; Wei W; Zhu Y; Guo J Mol Cancer; 2021 Aug; 20(1):100. PubMed ID: 34353330 [TBL] [Abstract][Full Text] [Related]
22. Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly. Shi Q; Zhu Y; Ma J; Chang K; Ding D; Bai Y; Gao K; Zhang P; Mo R; Feng K; Zhao X; Zhang L; Sun H; Jiao D; Chen Y; Sun Y; Zhao SM; Huang H; Li Y; Ren S; Wang C Mol Cancer; 2019 Nov; 18(1):170. PubMed ID: 31771591 [TBL] [Abstract][Full Text] [Related]
23. The diverse roles of SPOP in prostate cancer and kidney cancer. Wang Z; Song Y; Ye M; Dai X; Zhu X; Wei W Nat Rev Urol; 2020 Jun; 17(6):339-350. PubMed ID: 32355326 [TBL] [Abstract][Full Text] [Related]
24. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer. Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495 [TBL] [Abstract][Full Text] [Related]
25. The Roles of SPOP in DNA Damage Response and DNA Replication. Maekawa M; Higashiyama S Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023230 [TBL] [Abstract][Full Text] [Related]
26. SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex. Watanabe R; Maekawa M; Hieda M; Taguchi T; Miura N; Kikugawa T; Saika T; Higashiyama S Mol Biol Cell; 2020 Mar; 31(6):478-490. PubMed ID: 31967940 [TBL] [Abstract][Full Text] [Related]
27. Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP-HIPK2 axis. Jin X; Qing S; Li Q; Zhuang H; Shen L; Li J; Qi H; Lin T; Lin Z; Wang J; Cao X; Yang J; Ma Q; Cong L; Xi Y; Fang S; Meng X; Gong Z; Ye M; Wang S; Wang C; Gao K Nucleic Acids Res; 2021 Jul; 49(12):6788-6803. PubMed ID: 34133717 [TBL] [Abstract][Full Text] [Related]
28. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers. Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165 [TBL] [Abstract][Full Text] [Related]
29. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics. Wang H; Barbieri CE; He J; Gao Y; Shi T; Wu C; Schepmoes AA; Fillmore TL; Chae SS; Huang D; Mosquera JM; Qian WJ; Smith RD; Srivastava S; Kagan J; Camp DG; Rodland KD; Rubin MA; Liu T J Transl Med; 2017 Aug; 15(1):175. PubMed ID: 28810879 [TBL] [Abstract][Full Text] [Related]
30. Deregulation of SPOP in Cancer. Zhang H; Jin X; Huang H Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624 [TBL] [Abstract][Full Text] [Related]
31. Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation. Lai J; Batra J Asian J Androl; 2014; 16(5):659-60. PubMed ID: 24969063 [TBL] [Abstract][Full Text] [Related]
32. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6. Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312 [TBL] [Abstract][Full Text] [Related]
33. Speckle-type POZ protein, SPOP, is involved in the DNA damage response. Zhang D; Wang H; Sun M; Yang J; Zhang W; Han S; Xu B Carcinogenesis; 2014 Aug; 35(8):1691-7. PubMed ID: 24451148 [TBL] [Abstract][Full Text] [Related]
35. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836 [TBL] [Abstract][Full Text] [Related]
36. Identification of speckle-type POZ protein somatic mutations in African American prostate cancer. Buckles E; Qian C; Tadros A; Majumdar S; Cvitanovic J; Zabaleta J; Estrada J; Wilson J; Liu W Asian J Androl; 2014; 16(6):829-32. PubMed ID: 24994784 [TBL] [Abstract][Full Text] [Related]
37. Clinical and genomic features of SPOP-mutant prostate cancer. Nakazawa M; Fang M; H Marshall C; Lotan TL; Isaacsson Velho P; Antonarakis ES Prostate; 2022 Feb; 82(2):260-268. PubMed ID: 34783071 [TBL] [Abstract][Full Text] [Related]
38. The emerging role of SPOP protein in tumorigenesis and cancer therapy. Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237 [TBL] [Abstract][Full Text] [Related]
39. ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression. Fan Y; Hou T; Dan W; Zhu Y; Liu B; Wei Y; Wang Z; Gao Y; Zeng J; Li L Cell Death Differ; 2022 Aug; 29(8):1611-1624. PubMed ID: 35194188 [TBL] [Abstract][Full Text] [Related]
40. GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer. Burleson M; Deng JJ; Qin T; Duong TM; Yan Y; Gu X; Das D; Easley A; Liss MA; Yew PR; Bedolla R; Kumar AP; Huang TH; Zou Y; Chen Y; Chen CL; Huang H; Sun LZ; Boyer TG Mol Cancer Res; 2022 Jan; 20(1):62-76. PubMed ID: 34610962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]